This report provides a comprehensive analysis of the global enteric coated softgels for consumer health supplements market, forecasting steady growth through 2032. It examines key market dynamics, including technological advancements in manufacturing and the increasing role of innovative formulations in clinical research and development. The study offers detailed segmentation by material type, application channel, and geography, while evaluating the competitive landscape, strategic initiatives, and market positions of leading global industry players.

Market Overview

The global Enteric Coated Softgels For Consumer Health Spplements market is projected to grow from US$ 1927 million in 2025 to US$ 2547 million by 2032, representing a compound annual growth rate (CAGR) of 4.1% from 2026 to 2032.

Product Definition and Benefits

An enteric softgel capsule is an oral drug delivery system encapsulated in a gelatin-based shell designed to release its contents in the small intestine rather than the stomach.

• Composition: The gelatin shell may include glycerin and plasticizers, providing a flexible and easy-to-swallow format.
• Functionality: This specific formulation prevents the premature release of the encapsulated substance, making it ideal for drugs or supplements that are sensitive to gastric acids.
• Industry Applications: Commonly utilized in the pharmaceutical and nutraceutical industries.
• Key Benefits:
• Enhanced drug absorption
• Reduced gastrointestinal side effects
• Improved patient compliance, particularly for individuals with specific health considerations.

Market Growth Drivers and Trends

Technological Advancements in Manufacturing

The industry is experiencing growth driven by ongoing innovations that enhance the efficiency and precision of softgel capsule production, contributing to improved quality and cost-effectiveness. Key players are focusing on advanced manufacturing methodologies, emphasizing automation and novel techniques.

• Example: Catalent, Inc offers OptiGel DR Softgel Technology, which provides the capability to deliver an enteric release profile in a single-step manufacturing process without the need for additional coating. This commitment to technological progress boosts production capabilities and ensures a competitive market edge.

Clinical Research and Development Focus

Additional growth is being driven by an increasing focus on clinical trials for new technologies and formulations.

• Example: In October 2023, specialty chemicals leader Evonik introduced EUDRACAP, a preclinical functional oral capsule. This enteric-coated capsule serves as a valuable tool for pharmaceutical companies to optimize drug development during preclinical trials by reducing costs, time, and variables, thereby enhancing the efficiency of the development process.

Report Scope and Methodology

This research report by LPI (LP Information), titled “Enteric Coated Softgels For Consumer Health Spplements Industry Forecast,” provides a comprehensive analysis of the industry.

• Analysis Scope: The report reviews total world Enteric Coated Softgels For Consumer Health Spplements sales in 2025 and provides a detailed analysis of projected sales from 2026 through 2032.
• Key Insights: The report highlights trends related to product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
• Strategic Analysis: It examines the strategies of leading global companies, focusing on their portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
• Methodology: The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to provide a nuanced view of the market's current state and future trajectory.

Market Segmentation

By Type

• Type-A Gelatin (Pork Skin)
• Type-B Gelatin (Animal Bones & Skin)
• Starch Material
• Others

By Application

• Online
• Offline

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolio, and market penetration:

• Viva Pharmaceuticals
• Fuji Capsules Co. Ltd
• Aenova Group
• Captek Softgel International Inc
• Gelita AG
• Procaps Group
• InovoBiologic Inc
• Catalent, Inc
• Sirio Pharma Co., Ltd
• NOW Foods Inc.
• Renown Pharmaceuticals Pvt. Ltd.
• Lonza Group Ltd
• Basf SE

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Enteric Coated Softgels For Consumer Health Spplements Market Size (2021-2032)

    • 2.1.2 Enteric Coated Softgels For Consumer Health Spplements Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Enteric Coated Softgels For Consumer Health Spplements by Country/Region (2021, 2025 & 2032)

  • 2.2 Enteric Coated Softgels For Consumer Health Spplements Segment by Type

    • 2.2.1 Type-A Gelatin (Pork Skin)

    • 2.2.2 Type-B Gelatin (Animal Bones & Skin)

    • 2.2.3 Starch Material

    • 2.2.4 Others

    • 2.2.5 Enteric Coated Softgels For Consumer Health Spplements Market Size by Type

      • 2.2.5.1 Enteric Coated Softgels For Consumer Health Spplements Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.5.2 Global Enteric Coated Softgels For Consumer Health Spplements Market Size Market Share by Type (2021-2026)

  • 2.3 Enteric Coated Softgels For Consumer Health Spplements Segment by Application

    • 2.3.1 Online

    • 2.3.2 Offline

    • 2.3.3 Enteric Coated Softgels For Consumer Health Spplements Market Size by Application

      • 2.3.3.1 Enteric Coated Softgels For Consumer Health Spplements Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.3.2 Global Enteric Coated Softgels For Consumer Health Spplements Market Size Market Share by Application (2021-2026)

• 3 Enteric Coated Softgels For Consumer Health Spplements Market Size by Player

  • 3.1 Enteric Coated Softgels For Consumer Health Spplements Market Size Market Share by Player

    • 3.1.1 Global Enteric Coated Softgels For Consumer Health Spplements Revenue by Player (2021-2026)

    • 3.1.2 Global Enteric Coated Softgels For Consumer Health Spplements Revenue Market Share by Player (2021-2026)

  • 3.2 Global Enteric Coated Softgels For Consumer Health Spplements Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Enteric Coated Softgels For Consumer Health Spplements by Region

  • 4.1 Enteric Coated Softgels For Consumer Health Spplements Market Size by Region (2021-2026)

  • 4.2 Global Enteric Coated Softgels For Consumer Health Spplements Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Enteric Coated Softgels For Consumer Health Spplements Market Size Growth (2021-2026)

  • 4.4 APAC Enteric Coated Softgels For Consumer Health Spplements Market Size Growth (2021-2026)

  • 4.5 Europe Enteric Coated Softgels For Consumer Health Spplements Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Enteric Coated Softgels For Consumer Health Spplements Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Enteric Coated Softgels For Consumer Health Spplements Market Size by Country (2021-2026)

  • 5.2 Americas Enteric Coated Softgels For Consumer Health Spplements Market Size by Type (2021-2026)

  • 5.3 Americas Enteric Coated Softgels For Consumer Health Spplements Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Enteric Coated Softgels For Consumer Health Spplements Market Size by Region (2021-2026)

  • 6.2 APAC Enteric Coated Softgels For Consumer Health Spplements Market Size by Type (2021-2026)

  • 6.3 APAC Enteric Coated Softgels For Consumer Health Spplements Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Enteric Coated Softgels For Consumer Health Spplements Market Size by Country (2021-2026)

  • 7.2 Europe Enteric Coated Softgels For Consumer Health Spplements Market Size by Type (2021-2026)

  • 7.3 Europe Enteric Coated Softgels For Consumer Health Spplements Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Enteric Coated Softgels For Consumer Health Spplements by Region (2021-2026)

  • 8.2 Middle East & Africa Enteric Coated Softgels For Consumer Health Spplements Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Enteric Coated Softgels For Consumer Health Spplements Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Enteric Coated Softgels For Consumer Health Spplements Market Forecast

  • 10.1 Global Enteric Coated Softgels For Consumer Health Spplements Forecast by Region (2027-2032)

    • 10.1.1 Global Enteric Coated Softgels For Consumer Health Spplements Forecast by Region (2027-2032)

    • 10.1.2 Americas Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.1.3 APAC Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.1.4 Europe Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.1.5 Middle East & Africa Enteric Coated Softgels For Consumer Health Spplements Forecast

  • 10.2 Americas Enteric Coated Softgels For Consumer Health Spplements Forecast by Country (2027-2032)

    • 10.2.1 United States Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.2.2 Canada Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.2.3 Mexico Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.2.4 Brazil Market Enteric Coated Softgels For Consumer Health Spplements Forecast

  • 10.3 APAC Enteric Coated Softgels For Consumer Health Spplements Forecast by Region (2027-2032)

    • 10.3.1 China Enteric Coated Softgels For Consumer Health Spplements Market Forecast

    • 10.3.2 Japan Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.3.3 Korea Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.3.4 Southeast Asia Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.3.5 India Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.3.6 Australia Market Enteric Coated Softgels For Consumer Health Spplements Forecast

  • 10.4 Europe Enteric Coated Softgels For Consumer Health Spplements Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.4.2 France Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.4.3 UK Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.4.4 Italy Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.4.5 Russia Market Enteric Coated Softgels For Consumer Health Spplements Forecast

  • 10.5 Middle East & Africa Enteric Coated Softgels For Consumer Health Spplements Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.5.2 South Africa Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.5.3 Israel Market Enteric Coated Softgels For Consumer Health Spplements Forecast

    • 10.5.4 Turkey Market Enteric Coated Softgels For Consumer Health Spplements Forecast

  • 10.6 Global Enteric Coated Softgels For Consumer Health Spplements Forecast by Type (2027-2032)

  • 10.7 Global Enteric Coated Softgels For Consumer Health Spplements Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Enteric Coated Softgels For Consumer Health Spplements Forecast

• 11 Key Players Analysis

  • 11.1 Viva Pharmaceuticals

    • 11.1.1 Viva Pharmaceuticals Company Information

    • 11.1.2 Viva Pharmaceuticals Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.1.3 Viva Pharmaceuticals Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Viva Pharmaceuticals Main Business Overview

    • 11.1.5 Viva Pharmaceuticals Latest Developments

  • 11.2 Fuji Capsules Co. Ltd

    • 11.2.1 Fuji Capsules Co. Ltd Company Information

    • 11.2.2 Fuji Capsules Co. Ltd Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.2.3 Fuji Capsules Co. Ltd Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Fuji Capsules Co. Ltd Main Business Overview

    • 11.2.5 Fuji Capsules Co. Ltd Latest Developments

  • 11.3 Aenova Group

    • 11.3.1 Aenova Group Company Information

    • 11.3.2 Aenova Group Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.3.3 Aenova Group Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Aenova Group Main Business Overview

    • 11.3.5 Aenova Group Latest Developments

  • 11.4 Captek Softgel International Inc

    • 11.4.1 Captek Softgel International Inc Company Information

    • 11.4.2 Captek Softgel International Inc Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.4.3 Captek Softgel International Inc Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Captek Softgel International Inc Main Business Overview

    • 11.4.5 Captek Softgel International Inc Latest Developments

  • 11.5 Gelita AG

    • 11.5.1 Gelita AG Company Information

    • 11.5.2 Gelita AG Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.5.3 Gelita AG Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Gelita AG Main Business Overview

    • 11.5.5 Gelita AG Latest Developments

  • 11.6 Procaps Group

    • 11.6.1 Procaps Group Company Information

    • 11.6.2 Procaps Group Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.6.3 Procaps Group Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Procaps Group Main Business Overview

    • 11.6.5 Procaps Group Latest Developments

  • 11.7 InovoBiologic Inc

    • 11.7.1 InovoBiologic Inc Company Information

    • 11.7.2 InovoBiologic Inc Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.7.3 InovoBiologic Inc Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 InovoBiologic Inc Main Business Overview

    • 11.7.5 InovoBiologic Inc Latest Developments

  • 11.8 Catalent, Inc

    • 11.8.1 Catalent, Inc Company Information

    • 11.8.2 Catalent, Inc Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.8.3 Catalent, Inc Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Catalent, Inc Main Business Overview

    • 11.8.5 Catalent, Inc Latest Developments

  • 11.9 Sirio Pharma Co., Ltd

    • 11.9.1 Sirio Pharma Co., Ltd Company Information

    • 11.9.2 Sirio Pharma Co., Ltd Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.9.3 Sirio Pharma Co., Ltd Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Sirio Pharma Co., Ltd Main Business Overview

    • 11.9.5 Sirio Pharma Co., Ltd Latest Developments

  • 11.10 NOW Foods Inc.

    • 11.10.1 NOW Foods Inc. Company Information

    • 11.10.2 NOW Foods Inc. Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.10.3 NOW Foods Inc. Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 NOW Foods Inc. Main Business Overview

    • 11.10.5 NOW Foods Inc. Latest Developments

  • 11.11 Renown Pharmaceuticals Pvt. Ltd.

    • 11.11.1 Renown Pharmaceuticals Pvt. Ltd. Company Information

    • 11.11.2 Renown Pharmaceuticals Pvt. Ltd. Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.11.3 Renown Pharmaceuticals Pvt. Ltd. Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Renown Pharmaceuticals Pvt. Ltd. Main Business Overview

    • 11.11.5 Renown Pharmaceuticals Pvt. Ltd. Latest Developments

  • 11.12 Lonza Group Ltd

    • 11.12.1 Lonza Group Ltd Company Information

    • 11.12.2 Lonza Group Ltd Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.12.3 Lonza Group Ltd Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Lonza Group Ltd Main Business Overview

    • 11.12.5 Lonza Group Ltd Latest Developments

  • 11.13 Basf SE

    • 11.13.1 Basf SE Company Information

    • 11.13.2 Basf SE Enteric Coated Softgels For Consumer Health Spplements Product Offered

    • 11.13.3 Basf SE Enteric Coated Softgels For Consumer Health Spplements Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Basf SE Main Business Overview

    • 11.13.5 Basf SE Latest Developments

• 12 Research Findings and Conclusion